
Abortion Access Could Be Limited Further By Mifepristone Case
Was the FDA wrong to approve a drug that's used in nearly all medication abortions in the U.S. — and should the drug, mifepristone, be taken off the market? Those questions were argued in court Wednesday, in a case heard by federal Judge Matthew Kacsmaryk, a Trump appointee, in Amarillo, Texas. This episode: White House correspondent Tamara Keith, national correspondent Sarah McCammon, and political correspondent Susan Davis. The podcast is produced by Elena Moore and Casey Morell. It is edited by Eric McDaniel. Our executive producer is Muthoni Muturi. Research and fact-checking by Devin Speak. <br...
Publisher
The NPR Politics Podcast
Link
www.npr.org/2023/03/16/1164007535/abortion-access-could-be-limited-further-by-mifepristone-case
Published
March 16, 2023
Duration
14 min
Format
Podcast
Category
News · Daily News
Source
RSS feed
The NPR Politics Podcast
@nprpolitics
#abortionaccess #limitedfurther #mifepristonecase
